uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Omontys
Application withdrawn
Human
Details
EMA number
EMEA/H/C/002600
ATC code
B03XA
Authorisation
-
Revision
-
EMA page
Therapeutic indication
treatment of symptomatic anaemia associated with chronic kidney disease (CKD)
MeSH:
Anemia
Special characteristics
Conditional authorisation
Active substances
peginesatide
Marketing Authorisation Holder
Takeda Global Research and Development Centre (Europe)
MAH
Omontys | uMedical